Recent clinical research indicates that semaglutide may effectively reverse weight gain and blood sugar issues caused by ...

New FDA guidance signals a major shift for CAR-T development, calling for randomized trials with standard-of-care control groups and clear evidence of superiority over existing therapies, while ...

TXA is an inexpensive (approximately $3 per gram) and widely available antifibrinolytic medication with an established safety ...

The addition of ianalumab to eltrombopag significantly improved outcomes for patients with pretreated primary immune ...

A session at the AHA Scientific Sessions 2025 focused on dilemmas related to antithrombotic therapy following catheter ablation in patients with AF.

For traditional approval, CAR T therapies will need to establish superiority over current standard treatments, including ...

New medical research from heart and vascular experts at Intermountain Health is helping to improve heart care around the ...

In a randomized clinical trial, researchers compared the effect of single vs multiple treatment alternatives on care decisions.

Ocular Therapeutix announced it plans to accelerate its intended New Drug Application (NDA) for AXPAXLI (OTX-TKI) for the ...

MRD negativity post-chemotherapy strongly predicts improved overall survival in AML, with a significant reduction in mortality risk. The study suggests MRD could serve as an earlier surrogate endpoint ...

Provision of walking aids and related training for older adults in the emergency department may improve mobility and reduce ...

CHICAGO — Rosnilimab, a novel pathogenic T-cell depleting drug, met its primary endpoint of changes in DAS28 C-reactive ...